Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics - results from a German observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics - results from a German observational study ; volume:11 ; number:1 ; day:1 ; month:11 ; year:2011 ; pages:1-11 ; date:12.2011
BMC psychiatry ; 11, Heft 1 (1.11.2011), 1-11, 12.2011
- Urheber
-
Kraemer, Susanne
- Beteiligte Personen und Organisationen
-
Minarzyk, Anette
Forst, Thomas
Kopf, Daniel
Hundemer, Hans-Peter
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-11-173
- URN
-
urn:nbn:de:1111-2016030432249
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kraemer, Susanne
- Minarzyk, Anette
- Forst, Thomas
- Kopf, Daniel
- Hundemer, Hans-Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
A propensity score matching analysis for cardio metabolic risk of antipsychotics in patients with schizophrenia using Japanese claims data
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Gut microbiome and metabolism alterations in schizophrenia with metabolic syndrome severity
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
Metabolic Abnormality and Sleep Disturbance are Associated with Clinical Severity of Patients with Schizophrenia
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Relationship of metabolites and metabolic ratios with schizophrenia: a mendelian randomization study
![Antipsychotics : [with 47 tables]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Antipsychotics : [with 47 tables]
A propensity score matching analysis for cardio metabolic risk of antipsychotics in patients with schizophrenia using Japanese claims data
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Gut microbiome and metabolism alterations in schizophrenia with metabolic syndrome severity
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
Metabolic Abnormality and Sleep Disturbance are Associated with Clinical Severity of Patients with Schizophrenia
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Relationship of metabolites and metabolic ratios with schizophrenia: a mendelian randomization study
Antipsychotics : [with 47 tables]
A propensity score matching analysis for cardio metabolic risk of antipsychotics in patients with schizophrenia using Japanese claims data
Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?
Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Gut microbiome and metabolism alterations in schizophrenia with metabolic syndrome severity
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
Metabolic Abnormality and Sleep Disturbance are Associated with Clinical Severity of Patients with Schizophrenia
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Relationship of metabolites and metabolic ratios with schizophrenia: a mendelian randomization study